Related Experiment Video
Updated: Nov 25, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption.
Yinke Du1, Zhipeng Qi2, Jiangwei Ma3
1Department of Nephrology, First Hospital of China Medical University, Shenyang, China.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, often leading to a dangerous cytokine storm. Hemoadsorption therapy effectively removed inflammatory cytokines, benefiting a COVID-19 patient.
Area of Science:
- Infectious Diseases
- Immunology
- Critical Care Medicine
Background:
- The 2019 novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged globally in late 2019.
- Elevated plasma cytokine levels, including IL-6 and TNF-α, are linked to COVID-19 severity, indicating a cytokine storm.
Observation:
- Cytokine storms, characterized by excessive inflammation, are a hallmark of severe COVID-19.
- Extracorporeal blood purification techniques are recognized for their ability to mitigate cytokine release.
Findings:
- This case study details a COVID-19 patient experiencing a cytokine storm.
- The patient underwent hemoadsorption therapy, a form of extracorporeal blood purification.
Implications:
- Hemoadsorption demonstrated a positive clinical outcome in this severe COVID-19 case.
- This suggests hemoadsorption is a viable therapeutic option for managing cytokine storms in COVID-19 patients.
- Further research into extracorporeal blood purification for COVID-19 is warranted.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hemodialysis II: Procedure and Complications